We are live on
!
Find out more
EOJOAM
E. Ohman J:or Asset Management Portfolio holdings
AUM
$4.3B
1-Year Est. Return
29.55%
This Fund
S&P 500
This Quarter
Est. Return
+6.12%
1 Year Est. Return
+29.55%
3 Year Est. Return
+110.24%
5 Year Est. Return
+144.75%
10 Year Est. Return
+695.34%
AUM
$1.13B
AUM Growth
+$133M
(+13%)
Cap. Flow
+$76.8M
Cap. Flow
% of AUM
6.83%
Top 10 Holdings %
Top 10 Hldgs %
29.98%
Holding
565
New
6
Increased
343
Reduced
14
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$11.6M |
| 2 |
ICICI Bank
IBN
|
+$6.87M |
| 3 |
Verizon
VZ
|
+$6.14M |
| 4 |
Palo Alto Networks
PANW
|
+$6.09M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$4.65M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HOLX
Hologic
HOLX
|
+$5.32M |
| 2 |
AABA
Altaba Inc
AABA
|
+$4.73M |
| 3 |
MacroGenics
MGNX
|
+$3.45M |
| 4 |
Bank of America
BAC
|
+$2.88M |
| 5 |
RHT
Red Hat Inc
RHT
|
+$2.56M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.83% |
| 2 | Financials | 18.55% |
| 3 | Consumer Discretionary | 14.98% |
| 4 | Communication Services | 14.5% |
| 5 | Healthcare | 14.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
McKesson
MCK
$103B
| $829K | 0.07% |
5,400
+200
| +4% | +$31.2K |
|
177
Aflac
AFL
$61.2B
| $822K | 0.07% |
20,200
+800
| +4% | +$32.2K |
|
178
Progressive
PGR
$124B
| $813K | 0.07% |
16,800
+500
| +3% | +$23.4K |
|
|
FISV
179
Fiserv Inc
FISV
$27.8B
| $812K | 0.07% |
12,600
+400
| +3% | +$24.9K |
|
180
Sysco
SYY
$40.1B
| $798K | 0.07% |
14,800
+400
| +3% | +$20.8K |
|
181
Sherwin-Williams
SHW
$88.1B
| $788K | 0.07% |
6,600
| – | – |
|
182
Sempra
SRE
$55.1B
| $776K | 0.07% |
13,600
+400
| +3% | +$23.1K |
|
183
Lam Research
LRCX
$383B
| $768K | 0.07% |
41,500
+1,500
| +4% | +$24.3K |
|
|
APC
184
DELISTED
Anadarko Petroleum
APC
| $762K | 0.07% |
15,600
+500
| +3% | +$22.1K |
|
185
General Mills
GIS
$19.9B
| $761K | 0.07% |
14,700
+500
| +4% | +$27.4K |
|
186
Cummins
CMI
$87.4B
| $756K | 0.07% |
4,500
| – | – |
|
187
Roper Technologies
ROP
$39.9B
| $755K | 0.07% |
3,100
+700
| +29% | +$164K |
|
188
Weyerhaeuser
WY
$18.2B
| $746K | 0.07% |
21,920
+680
| +3% | +$22.3K |
|
|
PPL
189
PPL Corp
PPL
$26.3B
| $744K | 0.07% |
19,600
+600
| +3% | +$23.2K |
|
190
PACCAR
PCAR
$69.1B
| $734K | 0.07% |
15,225
+525
| +4% | +$23.7K |
|
191
Welltower
WELL
$169B
| $731K | 0.07% |
10,400
+300
| +3% | +$21.8K |
|
192
Corning
GLW
$136B
| $730K | 0.06% |
24,400
| – | – |
|
193
Ross Stores
ROST
$81.7B
| $730K | 0.06% |
11,300
+300
| +3% | +$17.3K |
|
194
Synchrony
SYF
$25.4B
| $728K | 0.06% |
23,448
+648
| +3% | +$19.4K |
|
195
Consolidated Edison
ED
$39.3B
| $718K | 0.06% |
8,900
+300
| +3% | +$24.8K |
|
196
Williams Companies
WMB
$87.9B
| $708K | 0.06% |
23,600
+700
| +3% | +$21.3K |
|
|
PXD
197
DELISTED
Pioneer Natural Resource Co.
PXD
| $708K | 0.06% |
4,800
+100
| +2% | +$14.4K |
|
198
Archer Daniels Midland
ADM
$38.8B
| $701K | 0.06% |
16,500
+500
| +3% | +$21.1K |
|
199
Equity Residential
EQR
$24.7B
| $699K | 0.06% |
10,600
+300
| +3% | +$20.1K |
|
200
AvalonBay Communities
AVB
$26.3B
| $696K | 0.06% |
3,900
+100
| +3% | +$18.7K |
|
Similar funds
IWM
CW
IUHSA
MYIA
NEI
CIC
SLI
E. Ohman J:or Asset Management's Q3 2017 Portfolio in Review
As of Q3 2017, E. Ohman J:or Asset Management held 565 positions worth $1.13B, up 13% from $992M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
E. Ohman J:or Asset Management deployed $76.8M of net new capital in Q3 2017, opening 6 new positions and adding to 343 existing holdings. Its largest new stake was Teva Pharmaceuticals: 206,483 shares worth $3.63M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Hologic, an estimated $5.32M trimmed.
- E. Ohman J:or Asset Management's largest Q3 2017 buy was Teva Pharmaceuticals: 206,483 shares worth $3.63M.
- E. Ohman J:or Asset Management added most to Eli Lilly in Q3 2017, an estimated $11.6M increase.
- E. Ohman J:or Asset Management's biggest Q3 2017 reduction was Hologic, cutting an estimated $5.32M.
- E. Ohman J:or Asset Management fully exited MacroGenics in Q3 2017, selling an estimated $3.45M.
- E. Ohman J:or Asset Management's ten largest holdings make up 30% of its $1.13B portfolio in Q3 2017.
- E. Ohman J:or Asset Management opened 6 new positions and closed 6 in Q3 2017.
- E. Ohman J:or Asset Management's portfolio value rose 13% quarter-over-quarter to $1.13B.
Based on E. Ohman J:or Asset Management's 13F filing for Q3 2017, filed 5 Apr 2024.